Stay updated on Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial

Sign up to get notified when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T23:40:02.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A new version dated 2026-09-28 adds updates to the study status and results, including participant flow, baseline characteristics, outcome measures, and adverse events. The quality-control review had not concluded, and the record was returned on 2026-10-19.
    Difference
    2%
    Check dated 2026-10-25T23:06:28.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T23:30:43.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T23:37:02.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The study record now indicates that results have been submitted, replacing the previous “No Results Posted” status.
    Difference
    0.1%
    Check dated 2026-10-04T23:05:18.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) has been added to the history, and the older revision entry (v3.6.6) has been removed from the change set.
    Difference
    0.1%
    Check dated 2026-09-20T22:51:02.000Z thumbnail image

Stay in the know with updates to Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.